CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rznomics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rznomics Inc
253, Pangyo-ro, Bundang-gu
Phone: +82 317068730p:+82 317068730 SEONGNAM, 13486  South Korea Fax: +82 3180188734f:+82 3180188734
Business Summary
Rznomics Inc is a Korea-based company principally engaged in the development of ribonucleic acid (RNA) editing and correction technologies. The Company’s main products include RNA editing enzyme-based gene therapies, self-circularized RNA structures, and RNA platform technologies. The Company sells its products in domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024-----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer Seong-WookLee 1/1/2024 1/1/2024
Chief Financial Officer Jong-SunRim 1/1/2024 1/1/2024
Chief Development Officer Sung WooHong 1/1/2024 1/1/2024
Internal Auditor Ju HyunLim 1/1/2024 1/1/2024
Non-Executive Independent Director Hee ChungKwon 1/1/2024 1/1/2024

General Information
Outstanding Shares: 11,651,556 (As of 11/14/2025)
Fax Number: +82 3180188734


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, December 4, 2025